Medical Education
0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Angel PharmaceuticalsChina - Zhejiang
1 programCommunity Service-Learning Anthropometric AssessmentN/A1 trial
Active Trials
Jerusalem PharmaceuticalsIsrael - Ramallah
1 programNbB psychopharmacology trainingN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Angel PharmaceuticalsCommunity Service-Learning Anthropometric Assessment
UNION therapeuticsAI agent
Jerusalem PharmaceuticalsNbB psychopharmacology training
Clinical Trials (3)
Total enrollment: 223 patients across 3 trials
Effect of a Community Service-Learning Intervention on Medical Empathy and Clinical Self-Efficacy in Medical Students
Start: Apr 2026Est. completion: May 202635 patients
N/ANot Yet Recruiting
cRCT of AI Agent in Clinital Resoning Training
Start: Apr 2026Est. completion: Aug 202688 patients
N/AEnrolling By Invitation
Neuroscience-based Nomenclature (NbN) as a Teaching Tool
Start: May 2020Est. completion: Sep 2021100 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.